Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Jimi Bio

Jimo Bio is a research and development company of cell-cultured meat.
2021
51-100
51-100
Xiaoshan, Zhejiang, China

Innovation

Industry Problem

Cell-derived food and consumer products need scalable cell lines, media and bioreactor processes that avoid harming animals.

R&D Focus

Mammalian cell culture, cultivated meat, cell-derived ingredients and culture reagents.

Innovative Solution

Establishes immortalized animal cell lines, grows them in proprietary media and scales production in bioreactors; also operates a high-throughput formulation platform.

Solution Effectiveness

The company reports more than one million cell experiments per day through its JEVOS platform, over 20 XR reagent products and more than 500 corporate and research clients.

Investment Funding

Last Funding Stage

Angel

Total Funding Amount

2.83M

Last Funding Date

08-03-2023

Startup Stage

Seed

Lead Investors

Plum Ventures, Joyvio Group, Green Leaf Ventures, Shiwei Venture Capital, Luye Investment Group

About

Jimi Biotechnology is dedicated to the advancement of grown meat products, particularly beef. The team includes cellular biologists, food materials experts, and aeronautical engineers with extensive experience in creating animal cell lines and developing serum-free medium.

Products

Product

XR culture reagents, Sikavira deer-antler cell extract, pet cell-therapy products and cultivated-meat technology.

Star Product

XR Series culture reagents – the largest current commercial line, with more than 20 products and 500 clients.

Demo Product or Complete Product?

Commercial cell-reagent and cell-derived consumer-product portfolio; cultivated meat remains under development.

M&A and Collabs

Collab

Strategic partnerships with major hospitals in several Chinese cities for Xiao Er pet cell-therapy applications.

Something missing or incorrect on this page? Help us enrich this information